Houin G - Search Results

1

[Prediction of carboplatin clearance from morphological and biological patient characteristics].

Chatelut E, Dezeuze A, Lavit M, Chevreau C, Pujol A, Boneu A, Roché H, Houin G, Bugat R, Canal P. Chatelut E, et al. Among authors: houin g. Bull Cancer. 1995 Nov;82(11):946-53. Bull Cancer. 1995. PMID: 8535021 French.

2

Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.

Chatelut E, Chevreau C, Blancy E, Lequellec A, Canal P, Roche H, Houin G, Bugat R. Chatelut E, et al. Among authors: houin g. Cancer Chemother Pharmacol. 1990;26(5):365-8. doi: 10.1007/BF02897295. Cancer Chemother Pharmacol. 1990. PMID: 2170043

3

[Comparison of the pharmacokinetics of cisplatin administered by the intraperitoneal route in 2 dosages: 100 and 200 mg/m2].

Canal P, Chatelut E, De Forni M, Chevreau C, Johnson N, Houin G, Bugat R. Canal P, et al. Among authors: houin g. Bull Cancer. 1989;76(8):879-82. Bull Cancer. 1989. PMID: 2620116 French. No abstract available.

4

[Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].

Chatelut E, Canal P, De Forni M, Chevreau C, Houin G, Bugat R. Chatelut E, et al. Among authors: houin g. Bull Cancer. 1989;76(8):893-6. Bull Cancer. 1989. PMID: 2620120 French. No abstract available.

5

[Relations between hematological toxicity and total and free plasma levels of etoposide in daily oral administration].

Lavit M, Chevreau C, Chatelut E, De Fenin V, Lochon I, Houin G, Bugat R, Canal P. Lavit M, et al. Among authors: houin g. Bull Cancer. 1995 Aug;82(8):660-4. Bull Cancer. 1995. PMID: 7492822 French.

6

Prediction of carboplatin clearance from standard morphological and biological patient characteristics.

Chatelut E, Canal P, Brunner V, Chevreau C, Pujol A, Boneu A, Roché H, Houin G, Bugat R. Chatelut E, et al. Among authors: houin g. J Natl Cancer Inst. 1995 Apr 19;87(8):573-80. doi: 10.1093/jnci/87.8.573. J Natl Cancer Inst. 1995. PMID: 7752255

7

A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.

Chatelut E, Chevreau C, Brunner V, Martinez M, Houin G, Bugat R, Canal P. Chatelut E, et al. Among authors: houin g. Cancer Chemother Pharmacol. 1995;35(5):391-6. doi: 10.1007/s002800050252. Cancer Chemother Pharmacol. 1995. PMID: 7850920 Clinical Trial.

8

Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysis-dependent renal insufficiency.

Chatelut E, Rostaing L, Gualano V, Vissac T, De Forni M, Ton-That H, Suc JM, Houin G, Canal P. Chatelut E, et al. Among authors: houin g. Nephron. 1994;66(2):157-61. doi: 10.1159/000187794. Nephron. 1994. PMID: 8139735

9

Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas.

Canal P, Attal M, Chatelut E, Guichard S, Huguet F, Muller C, Schlaifer D, Laurent G, Houin G, Bugat R. Canal P, et al. Among authors: houin g. Cancer Res. 1993 Oct 15;53(20):4850-4. Cancer Res. 1993. PMID: 8402672 Clinical Trial.

10

Population pharmacokinetics of total and unbound etoposide.

Nguyen L, Chatelut E, Chevreau C, Tranchand B, Lochon I, Bachaud JM, Pujol A, Houin G, Bugat R, Canal P. Nguyen L, et al. Among authors: houin g. Cancer Chemother Pharmacol. 1998;41(2):125-32. doi: 10.1007/s002800050718. Cancer Chemother Pharmacol. 1998. PMID: 9443625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters